|
METTL2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.05739999978205E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.361300E-04 |
| Normal-vs-Stage2 |
5.150000E-02 |
| Normal-vs-Stage3 |
3.372000E-02 |
| Normal-vs-Stage4 |
4.222000E-02 |
| Stage1-vs-Stage2 |
7.334400E-01 |
| Stage1-vs-Stage3 |
9.776800E-01 |
| Stage1-vs-Stage4 |
1.850610E-01 |
| Stage2-vs-Stage3 |
7.463400E-01 |
| Stage2-vs-Stage4 |
3.835400E-01 |
| Stage3-vs-Stage4 |
2.062200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.15049999994366E-07 |
| Normal-vs-AfricanAmerican |
2.479800E-03 |
| Normal-vs-Asian |
5.422200E-01 |
| Caucasian-vs-AfricanAmerican |
6.447800E-01 |
| Caucasian-vs-Asian |
6.042600E-01 |
| AfricanAmerican-vs-Asian |
6.770800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.51229999999703E-05 |
| Normal-vs-Female |
1.42030000005455E-06 |
| Male-vs-Female |
4.128300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.045700E-02 |
| Normal-vs-Extreme_Weight |
4.060300E-03 |
| Normal-vs-Obese |
1.196720E-03 |
| Normal-vs-Extreme_Obese |
2.322400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.999600E-01 |
| Normal_Weight-vs-Obese |
6.134600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.928800E-01 |
| Extreme_Weight-vs-Obese |
5.496000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.758000E-01 |
| Obese-vs-Extreme_Obese |
9.874800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.600900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.21840000036444E-07 |
| Normal-vs-Age(61-80Yrs) |
1.382640E-03 |
| Normal-vs-Age(81-100Yrs) |
6.395400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.792200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.577400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.263100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.790200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.542250E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.159190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.4766000000499E-07 |
| Normal-VS-Type2 PRCC |
1.410240E-02 |
| Normal-VS-KIRP CIMP |
5.439600E-02 |
| Normal-VS-Unclassified PRCC |
1.042310E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.565200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.742800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.881800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.342000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.929400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.078400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.452600E-01 |
| Normal-vs-N1 |
1.634470E-02 |
| Normal-vs-N2 |
4.518400E-01 |
| N0-vs-N1 |
1.028420E-01 |
| N0-vs-N2 |
5.226200E-01 |
| N1-vs-N2 |
7.901200E-01 |
|
|
